A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Aims To compare the duration of the residual hypnotic and sedative effects of zaleplon with those of zolpidem and placebo following nocturnal administration at various times before morning awakening. Methods Zaleplon 10 mg, zolpidem 10 mg, or placebo was administered double‐blind to 36 healthy subjects under standardized conditions in a six‐period, incomplete‐block, crossover study. Subjects were gently awakened and given medication at predetermined times 5, 4, 3, or 2 h before morning awakening, which occurred 8 h after bedtime. When the subjects awoke in the morning, a battery of subjective and objective assessments of residual effects of hypnotics was administered. Results No residual effects were demonstrated after zaleplon 10 mg, when administered as little as 2 h before waking, on either subjective or objective assessments, whereas zolpidem 10 mg showed significant residual effects on DSST and memory (immediate and delayed free recall) after administration up to 5 h before waking and choice reaction time, critical flicker fusion threshold and Sternberg memory scanning after administration up to 4 h before waking. Residual effects of zolpidem were apparent in all objective and subjective measurements when the drug was administered later in the night. Conclusions The present results demonstrate that zaleplon at the dose of 10 mg is free of residual hypnotic or sedative effects when administered nocturnally as little as 2 h before waking in normal subjects. In contrast, residual effects of zolpidem are still apparent on objective assessments up to 5 h after nocturnal administration, longer than has been reported from studies involving daytime administration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rebound Insomnia and Rebound Anxiety: A Review
Kales, A., Soldatos, C. R., Bixler, E. O., & Kales, J. D. (2008) · Pharmacology · doi:10.1159/000137794 · Cited by 198
Chronic use of benzodiazepines and psychomotor and cognitive test performance
Lucki, I., Rickels, K., & Geller, A. (1986) · Psychopharmacology · doi:10.1007/bf00178503 · Cited by 186
Cited by
Critical flicker frequency for quantification of low-grade hepatic encephalopathy
Kircheis, G., Wettstein, M., Timmermann, L., Schnitzler, A., & Häussinger, D. (2002) · Hepatology · doi:10.1053/jhep.2002.30957 · Cited by 397
Sleep disturbances in the wake of traumatic events
Lavie, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmra012893 · Cited by 362
Zolpidem: A Review of Its Use in the Management of Insomnia
Swainston Harrison, T., & Keating, G. M. (2005) · CNS Drugs · doi:10.2165/00023210-200519010-00008 · Cited by 323
Holm, K. J., & Goa, K. L. (2000) · Drugs · doi:10.2165/00003495-200059040-00014 · Cited by 317
Zaleplon: A Review of its Use in the Treatment of Insomnia
Dooley, M., & Plosker, G. L. (2000) · Drugs · doi:10.2165/00003495-200060020-00014 · Cited by 287
Metadata
- Authors
- Danjou, Paty, Fruncillo, Worthington, Unruh, Cevallos, & Martin
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1999-09
- Volume
- 48
- Issue
- 3
- Pages
- 367-374
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W2124423795
- Cited by
- 113
- References
- 2
- FWCI
- 13.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening. https://app.cochat.ai/papers/10.1046/j.1365-2125.1999.00024.x
- The paper
- Danjou, Paty, Fruncillo, Worthington, Unruh, Cevallos, & Martin. (1999). A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening. British Journal of Clinical Pharmacology. https://doi.org/10.1046/j.1365-2125.1999.00024.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.